Stay updated on AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page
- CheckyesterdayChange DetectedThe page history now includes a new revision entry v3.3.4, and the prior v3.3.3 entry was removed from the history list. This is a minor update to the revision log and does not affect study data or trial outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page history now includes Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2, which are administrative updates to the history entries rather than changes to the study data.SummaryDifference0.2%

- Check51 days agoChange DetectedRevision history shows addition of version v3.3.2 and removal of v3.2.0.SummaryDifference0.1%

- Check58 days agoChange DetectedThe notice about government funding and operating status was removed from the page.SummaryDifference0.8%

- Check72 days agoChange DetectedThe History page shows slight wording changes for the Quality Control status and minor layout adjustments in the study record versions section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check101 days agoChange DetectedThe page has been updated to announce a new version (v3.2.0) and to provide a government-operating-status notice, indicating current status and where to check for updates.SummaryDifference12%

Stay in the know with updates to AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page.